MoneyWorks4Me

Granules India invests additional $20 million in Granules Pharmaceuticals

30 Jan 2017 Evaluate

Granules India has received an approval for further investment of $20 million in Granules Pharmaceuticals Inc., a wholly owned subsidiary of the company. The board of directors at its meeting held on January 28, 2017 has approved for the same.

Granules India is a pharmaceutical company with presence across the pharmaceutical manufacturing value chain, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs) and finished dosages (FDs).


Peers
Company Name CMP
Sun Pharma. Inds. 1853.15
Dr. Reddys Labs. 1190.20
Cipla 1374.60
Lupin 2087.65
Zydus Lifesciences 1154.80
View more..